Seasonal Influenza – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Seasonal Influenza – Drugs In Development, 2024 report and make more profitable business decisions.
Seasonal influenza, commonly referred to as “the flu”, is a contagious respiratory illness caused by influenza viruses. It typically occurs in outbreaks during the fall and winter months, peaking between December and February in the Northern Hemisphere. The flu can cause mild to severe illness and, in some cases, can lead to hospitalization or even death, especially among vulnerable populations. Symptoms of the flu include fever, cough, sore throat, runny or stuffy nose, body aches, fatigue, headaches, and sometimes vomiting or diarrhea, especially in children. The flu virus spreads primarily through respiratory droplets when an infected person coughs, sneezes, or talks. It can also spread by touching a surface or object contaminated with the virus and then touching the mouth, nose, or eyes.
The Seasonal Influenza drugs in development market research report provide comprehensive information on the therapeutics under development for Seasonal Influenza, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Seasonal Influenza and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Seasonal Influenza | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 63 molecules, with 57 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Seasonal Influenza therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Seasonal Influenza pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Seasonal Influenza treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Adimmune CorpBioNTech SE
Centivax Inc
CHA Vaccine Institute Co Ltd
Cidara Therapeutics Inc
Cilian AG
Clover Biopharmaceuticals Ltd
Cocrystal Pharma Inc
ContraFect Corp
CSL Ltd
Curevac NV
Dynavax Technologies Corp
ENA Respiratory Pty Ltd
Etna Biotech Srl
Evrys Bio
Expres2ion Biotechnologies ApS
FluGen Inc
Georgia State University
GreenLight Biosciences Holdings PBC
GSK plc
Invivyd Inc
iosBio Pharma Ltd
Jiangsu Kangrun Biological Technology Co Ltd
LiteVax BV
Longhorn Vaccines and Diagnostics LLC
Medigen Vaccine Biologics Corp
Mercia Pharma Inc
Moderna Inc
Mynvax Pvt Ltd
New Amsterdam Sciences Inc
Novavax Inc
Ocugen Inc
Respana Therapeutics Inc
SAB Biotherapeutics Inc
Sanofi
Scientific Research Institute for Biological Safety Problems
Seqirus Ltd
Sinovac Biotech Ltd
SiVEC Biotechnologies LLC
Sumitomo Pharma Co Ltd
Sunomix Therapeutics
TechnoVax Inc
Tehran University of Medical Sciences
The Institute of Vaccines and Medical Biologicals
The University of British Columbia
University of Wisconsin Madison
Vaxart Inc
Vaxess Technologies Inc
Vaxxas Pty Ltd
Viramatix Sdn Bhd
VLP Therapeutics LLC
XBiotech Inc
Zhejiang Tianyuan Bio-Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Seasonal Influenza reports